|
⚲
|
| Keyboard |
| Kindly MD Inc | |
|---|---|
| Ticker | NAKA |
| CIK # | 0001946573 |
| CUSIP | 49457M106 |
| Sector | Life Sciences - Services-Health Services |
| Address | 5097 South 900 East Suite 100, Salt Lake City, UT 84117 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Kindly MD Inc | 2025-07-08 | 51.5 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001946573] | 10-K | |
| [0001946573] | 10-Q | |
| [0001946573] | 3 | |
| [0001946573] | 4 | |
| [0001946573] | 8-K | |
| [0001946573] | D | |
| [0001946573] | SC 13D | |
| [0001946573] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Bailey David F | Nakamoto Inc | [2026-02-27] | 0.0 |
| Bailey Calli Sullivan | Nakamoto Inc | [2026-02-26] | 0.0 |
| Alyeska Investment Group LP | Nakamoto Inc | [2026-02-17] | 0.0 |
| GUS Doodle LLC | Kindly MD Inc | [2025-05-23] | 0.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Evans Tyler Matthew
Common Stock
|
2026-03-12 | Grant | 600,000 | $0.00 | |
|
Common Stock
|
2026-02-20 | Grant | 17,841,993 | $0.00 | |
|
Evans Tyler Matthew
Common Stock
|
2026-02-20 | Grant | 17,841,993 | $0.00 | |
|
Bailey David F
Common Stock
|
2026-02-20 | Grant | 108,200,628 | $0.00 | |
|
Stock Option · derivative
|
2026-02-20 | Grant | 3,596,392 | ||
|
Stock Option · derivative
|
2026-02-20 | Grant | 12,491,284 | ||
|
Stock Option · derivative
|
2026-02-20 | Grant | 2,470,803 | ||
|
Stock Option · derivative
|
2026-02-20 | Grant | 4,118,006 | ||
|
Stock Option · derivative
|
2026-02-20 | Grant | 2,745,337 | ||
|
Evans Tyler Matthew
Stock Option · derivative
|
2026-02-20 | Grant | 4,118,006 | ||
|
Evans Tyler Matthew
Stock Option · derivative
|
2026-02-20 | Grant | 2,470,803 | ||
|
Evans Tyler Matthew
Stock Option · derivative
|
2026-02-20 | Grant | 3,596,392 | ||
|
Evans Tyler Matthew
Stock Option · derivative
|
2026-02-20 | Grant | 2,745,337 | ||
|
Evans Tyler Matthew
Stock Option · derivative
|
2026-02-20 | Grant | 12,491,284 | ||
|
Creighton Andrew John
Stock Option · derivative
|
2026-02-20 | Grant | 1,685,500 | ||
|
Dalton John Merritt
Common Stock
|
2025-12-16 | Grant | 1,574,803 | $0.00 | |
|
Gendron Teresa S
Common Stock
|
2025-12-16 | Grant | 2,624,671 | $0.00 | |
|
Common Stock
|
2025-09-22 | Grant | 6,400 | $0.00 | |
|
Common Stock
|
2025-09-22 | Grant | 26,129 | $0.00 | |
|
Common Stock
|
2025-09-22 | Grant | 10,146 | $0.00 | |
| showing 20 of 52 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 62 | 129,329,033 |
| 2025-12-31 | 64 | 135,175,942 |
| 2025-09-30 | 54 | 107,157,658 |
| 2025-06-30 | 12 | 138,394 |
| 2025-03-31 | 11 | 998,342 |
| 2024-12-31 | 8 | 839,264 |
| 2024-09-30 | 4 | 701,409 |
| 2024-06-30 | 4 | 72,263 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares | Prev | Page 1 | Next |